![]()
Douglas Crawford, an architect of the University of California's effort to swing biotechnology from academic lab benches to commercial partners and spinouts, has left UC to work full time at a public-private incubator and early-stage venture fund firm he was instrumental in creating.
As associate director of QB3 — or the California Institute for Quantitative Biosciences — Crawford's fingerprints are on scores of life sciences companies that have set up shop or spun out of the institute's four…